GE HealthCare Technologies (GEHC) EBITDA Margin (2022 - 2026)
GE HealthCare Technologies (GEHC) reported EBITDA Margin of 10.04% for Q1 2026, down 313.0% on a YoY basis from 4.71% in Q1 2025, and down 30.85% quarter-over-quarter from 14.51% in Q4 2025.
GE HealthCare Technologies (GEHC) EBITDA Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies has reported EBITDA Margin for 5 years, with the latest figure at 10.04% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 313.0% year-over-year to 10.04%; the trailing twelve-month figure through Mar 2026 stood at 12.63% (down 108.0% YoY), and the FY2025 full-year result was 13.4%, up 5.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 10.04%, down from 14.51% in the prior quarter.
- The five-year high for EBITDA Margin was 15.74% in Q4 2022, with the low at 10.04% in Q1 2026.
- Historically, EBITDA Margin has averaged 13.01% across 5 years, with a median of 13.06% in 2025.
- Annual changes were most pronounced in 2024 — EBITDA Margin surged 182 bps — and 2026, when it sank 313 bps.
- GE HealthCare Technologies' EBITDA Margin stood at 15.74% in 2022, then decreased by 16 bps to 13.23% in 2023, then gained by 14 bps to 15.06% in 2024, then declined by 4 bps to 14.51% in 2025, then tumbled by 31 bps to 10.04% in 2026.
- The last three EBITDA Margin figures came in at 10.04% (Q1 2026), 14.51% (Q4 2025), and 12.7% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 17.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.04% |
| Dec 31, 2025 | 14.51% |
| Sep 30, 2025 | 12.70% |
| Jun 30, 2025 | 13.06% |
| Mar 31, 2025 | 13.17% |
| Dec 31, 2024 | 15.06% |
| Sep 30, 2024 | 13.90% |
| Jun 30, 2024 | 12.56% |
| Mar 31, 2024 | 11.61% |
| Dec 31, 2023 | 13.23% |
| Sep 30, 2023 | 12.80% |
| Jun 30, 2023 | 11.83% |
| Mar 31, 2023 | 11.88% |
| Dec 31, 2022 | 15.74% |
| Sep 30, 2022 | 13.22% |
| Jun 30, 2022 | 14.07% |
| Mar 31, 2022 | 11.72% |